SAN DIEGO, Calif.--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the launch of Illumina?Connect, a bioinformatics software partnership program established to advance data integration and analysis. This program offers Illumina customers seamless access to third-party bioinformatics providers of advanced data analysis applications for processing Illumina array data. Customers who have upgraded to Illumina’s new BeadStudio 3.0 Data Analysis Software for analyzing genotyping, gene expression, and copy number variation (CNV) analysis can now take full advantage of additional statistical and advanced algorithms afforded by this new program.
